Home
>
National Drug Code (NDC)
>
Reglan
Reglan - 60977-451-03 - (METOCLOPRAMIDE HYDROCHLORIDE)
Drug Information of Reglan
| Product NDC: | 60977-451 |
| Proprietary Name: | Reglan |
| Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
| Active Ingredient(s): | 5 mg/mL & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Reglan
| Product NDC: | 60977-451 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017862 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101209 |
Package Information of Reglan
| Package NDC: | 60977-451-03 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-03) > 30 mL in 1 VIAL, SINGLE-DOSE (60977-451-82) |
NDC Information of Reglan
| NDC Code | 60977-451-03 |
| Proprietary Name | Reglan |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-03) > 30 mL in 1 VIAL, SINGLE-DOSE (60977-451-82) |
| Product NDC | 60977-451 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20101209 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |
